RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 129 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $602,707 | -17.8% | 558,062 | -1.8% | 0.00% | – |
| Q2 2023 | $733,029 | -0.3% | 568,239 | +2.0% | 0.00% | – |
| Q1 2023 | $735,030 | -13.2% | 556,841 | -1.4% | 0.00% | – |
| Q4 2022 | $846,968 | +26.2% | 564,645 | -0.7% | 0.00% | – |
| Q3 2022 | $671,000 | +13.3% | 568,712 | +8.6% | 0.00% | – |
| Q2 2022 | $592,000 | -64.3% | 523,609 | -5.4% | 0.00% | – |
| Q1 2022 | $1,656,000 | +13.2% | 553,621 | +0.3% | 0.00% | – |
| Q4 2021 | $1,463,000 | -25.6% | 552,174 | +1.9% | 0.00% | – |
| Q3 2021 | $1,967,000 | -11.5% | 542,015 | +5.9% | 0.00% | – |
| Q2 2021 | $2,222,000 | +4.9% | 511,935 | -17.3% | 0.00% | – |
| Q1 2021 | $2,118,000 | -9.6% | 619,161 | -7.6% | 0.00% | -100.0% |
| Q4 2020 | $2,344,000 | +44.9% | 669,956 | -0.6% | 0.00% | – |
| Q3 2020 | $1,618,000 | +29.0% | 674,131 | -1.7% | 0.00% | – |
| Q2 2020 | $1,254,000 | +16.7% | 685,481 | -0.5% | 0.00% | – |
| Q1 2020 | $1,075,000 | -27.1% | 688,933 | 0.0% | 0.00% | – |
| Q4 2019 | $1,474,000 | +16.4% | 688,933 | +1.8% | 0.00% | – |
| Q3 2019 | $1,266,000 | -32.1% | 677,012 | -5.3% | 0.00% | -100.0% |
| Q2 2019 | $1,865,000 | +1.4% | 714,537 | -0.2% | 0.00% | 0.0% |
| Q1 2019 | $1,840,000 | +11.8% | 716,091 | +0.1% | 0.00% | 0.0% |
| Q4 2018 | $1,646,000 | -25.8% | 715,482 | +3.5% | 0.00% | 0.0% |
| Q3 2018 | $2,218,000 | +5.0% | 691,046 | -7.4% | 0.00% | 0.0% |
| Q2 2018 | $2,112,000 | -21.0% | 746,322 | -1.2% | 0.00% | 0.0% |
| Q1 2018 | $2,674,000 | -8.0% | 755,460 | +0.9% | 0.00% | 0.0% |
| Q4 2017 | $2,905,000 | +106.9% | 748,963 | +35.4% | 0.00% | – |
| Q3 2017 | $1,404,000 | -7.4% | 553,172 | -0.4% | 0.00% | – |
| Q2 2017 | $1,516,000 | -20.8% | 555,517 | -4.0% | 0.00% | -100.0% |
| Q1 2017 | $1,915,000 | +79.8% | 578,414 | +29.3% | 0.00% | – |
| Q4 2016 | $1,065,000 | -32.4% | 447,252 | +4.2% | 0.00% | – |
| Q3 2016 | $1,575,000 | +61.7% | 429,114 | -1.8% | 0.00% | – |
| Q2 2016 | $974,000 | +4.3% | 436,771 | -2.8% | 0.00% | – |
| Q1 2016 | $934,000 | -27.7% | 449,285 | +5.5% | 0.00% | – |
| Q4 2015 | $1,291,000 | +22.1% | 425,945 | -0.4% | 0.00% | – |
| Q3 2015 | $1,057,000 | -35.4% | 427,822 | -16.1% | 0.00% | – |
| Q2 2015 | $1,636,000 | -8.3% | 509,699 | +1.9% | 0.00% | – |
| Q1 2015 | $1,785,000 | +46.1% | 500,027 | -7.1% | 0.00% | – |
| Q4 2014 | $1,222,000 | +20.2% | 538,123 | +2.6% | 0.00% | – |
| Q3 2014 | $1,017,000 | -70.5% | 524,399 | -44.8% | 0.00% | – |
| Q2 2014 | $3,450,000 | +81.4% | 950,540 | +93.9% | 0.00% | -100.0% |
| Q1 2014 | $1,902,000 | +49.4% | 490,298 | +9.8% | 0.00% | – |
| Q4 2013 | $1,273,000 | -59.5% | 446,708 | -49.1% | 0.00% | – |
| Q3 2013 | $3,142,000 | +107.7% | 877,664 | +93.7% | 0.00% | – |
| Q2 2013 | $1,513,000 | – | 453,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |